STAT3 regulatedmiR-216apromotes ovarian cancer proliferation and cisplatin resistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT3 regulatedmiR-216apromotes ovarian cancer proliferation and cisplatin resistance
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 38, Issue 4, Pages BSR20180547
Publisher
Portland Press Ltd.
Online
2018-07-31
DOI
10.1042/bsr20180547
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers
- (2018) Yu Han et al. JOURNAL OF CONTROLLED RELEASE
- miR-455 inhibits breast cancer cell proliferation through targeting CDK14
- (2017) Bing Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells
- (2016) Jing Song et al. CANCER SCIENCE
- Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
- (2016) U Saini et al. ONCOGENE
- Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway
- (2015) Wei Xu et al. CANCER LETTERS
- miR-216a may inhibit pancreatic tumor growth by targeting JAK2
- (2015) Bao-hua Hou et al. FEBS LETTERS
- Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex
- (2015) Jong-Hwan Lee et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line
- (2015) Jian-Huang Li et al. TUMOR BIOLOGY
- Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
- (2015) Yan Gao et al. Oncotarget
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- MicroRNA Processing and Human Cancer
- (2015) Masahisa Ohtsuka et al. Journal of Clinical Medicine
- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
- (2014) Christopher J. Cheng et al. NATURE
- MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2
- (2014) SILIANG WANG et al. ONCOLOGY REPORTS
- A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer
- (2014) Lin Wang et al. PLoS One
- Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly
- (2013) X. Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Abstract 4412: Prognostic significance of NF-κB in Middle Eastern diffuse large B cell lymphoma and efficacy of NF-κB inhibition as a viable therapeutic target
- (2012) Prashant Bavi et al. CANCER RESEARCH
- Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
- (2012) D. J. Mulholland et al. CANCER RESEARCH
- miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma
- (2011) Min Deng et al. JOURNAL OF CELL SCIENCE
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
- (2010) Dimitrios Iliopoulos et al. MOLECULAR CELL
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
- (2010) S L Cooke et al. ONCOGENE
- Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis
- (2010) Xiang-Yu Kong WORLD JOURNAL OF GASTROENTEROLOGY
- BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells
- (2009) M. Mani et al. CANCER RESEARCH
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression
- (2009) Yu Nakamura et al. INTERNATIONAL JOURNAL OF CANCER
- Maintenance Therapy for Ovarian Cancer: Of Helsinki and Hippocrates
- (2009) William Patrick McGuire JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
- (2008) Neetu Dahiya et al. PLoS One
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More